Artificial Intelligence Model Predicts Overall Survival in Patients with Metastatic Breast Cancer

Oncology Times - OncTimes Talk

A mathematical study of real-world data from 27,855 women whose breast cancer was diagnosed between 2008 and 2020 has shown that a machine-learning artificial intelligence algorithm was able to predict mortality and could become a key weapon in the clinician’s armory when selecting therapies on the basis of predicted survival. Initial findings and conclusions from the study were reported at the European Society for Medical Oncology (ESMO) Breast Cancer Congress 2023.

First author of the study, Laura Vuduc from the Department of Applied Mathematics at CentraleSupélec, Paris-Saclay University in Gif-sur-Yvette near Paris, France, talked about the importance of this new development with OncTimesTalk correspondent, Peter Goodwin.